在脂质纳米颗粒上优化聚乙烯糖醇屏蔽和曼诺酸密度,以有效地传递给巨细胞和脏
Sangho Yeo1, Hyeondo Lee1, Junhyuk Lee1
1Department of Bioscience and Biotechnology, Konkuk University, Seoul 143-701, Republic of Korea.
International journal of pharmaceutics
|July 29, 2024
概括
优化脂质纳米粒子 (LNP) 表面修饰与聚乙烯糖醇 (PEG) 屏蔽和曼诺酸对巨细胞吸收和脏积累的影响不同. 量身定制的LNP设计增强了药物输送的脏向.
科学领域:
- 生物技术是生物技术.
- 纳米医学是一种纳米医学.
- 药物输送系统 药物输送系统
背景情况:
- 脂质纳米粒子 (LNP) 对于提供基于核酸的疗法至关重要.
- 控制LNP表面特性,如聚乙烯糖醇 (PEG) 屏蔽和连接体密度,对于有针对性的输送至关重要.
- 了解修改后的LNP的体外和体内行为对于优化其治疗潜力至关重要.
研究的目的:
- 调查不同聚乙烯糖醇 (PEG) 屏蔽和曼诺糖结合联结体密度对脂质纳米粒子 (LNP) 的影响.
- 为了比较巨细胞对修改后的LNP的体内细胞内吸收与它们在脏中的体内积累.
- 为了确定最佳的LNP表面修改,以提高 targeting.
主要方法:
- 用各种密度 (00.6 PEGs/nm2) 的曼诺结合的DSPE-PEG (DPM) 装饰的酸胺结合的LNP (sLNP) 的制造.
- 在体外评估巨细胞 (RAW 264.7细胞) 吸收不同PEG屏蔽水平的sLNP-DPM.
- 在小鼠内静脉注射修改的sLNP后,包括那些混合PEG和DPM涂层的sLNP,体内评估脏积累.
主要成果:
- 在sLNP上较低的PEG屏蔽与曼诺斯配体增强了体外巨细胞吸收.
- 在sLNP-DPM上更高的PEG屏蔽导致了显著更大的体内脏积累.
- 使用特定混合DSPE-methoxyPEG (DP) 和DPM (5/5比率) 的sLNP显示,与裸体sLNP相比,脏红色肉质积累增加了2.7倍.
结论:
- 对于LNP来说,最佳的PEG屏蔽和曼诺斯配体密度在体外巨细胞吸收和体内脏积累之间有所不同.
- 精确地定制LNP表面修饰,平衡PEG屏蔽和曼诺斯密度,可以显著改善脏红肉质中的积累.
- 这些发现支持优化LNP的应用,以便在体内向脏提供基于核酸的药物和疫苗.
相关概念视频
Bioavailability Enhancement: Drug Permeability Enhancement
After oral administration, poor permeability often limits the rate at which drugs are absorbed through the intestinal epithelium. Enhancing drug permeability is crucial for effective therapy, and several strategies have been developed to overcome this challenge.One effective strategy involves the use of lipid-based formulations. These formulations enhance dissolution and solubility, targeting physiological mechanisms to increase drug absorption. This includes stimulating bile salt secretion,...
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...


